Growth Metrics

Cytosorbents (CTSO) Asset Writedowns and Impairment (2016 - 2026)

Cytosorbents posted quarterly Asset Writedowns and Impairment of $300000.0 for Q1 2026, up 3650.0% year-on-year from $8000.0 in Q1 2025, and up 320.59% on a QoQ basis from -$136000.0 in Q4 2025.

Cytosorbents (CTSO) has 11 years of Asset Writedowns and Impairment data on file, last reported at $300000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 3650.0% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $332000.0 (up 465.55% YoY), and the FY2025 full-year result was $40000.0, down 65.22% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $300000.0, up from -$136000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $462237.0 in Q3 2023 and bottomed at -$421057.0 in Q3 2022.
  • The 5-year median for Asset Writedowns and Impairment is $64296.0 (2024), against an average of $64843.0.
  • The widest annual swing landed in 2022, when Asset Writedowns and Impairment slumped 6960.96%; it then soared 3650.0% in 2026.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$18723.0 in 2022, then soared by 1061.73% to $180064.0 in 2023, then slumped by 95.56% to $8000.0 in 2024, then slumped by 1800.0% to -$136000.0 in 2025, then jumped by 320.59% to $300000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $300000.0 (Q1 2026), -$136000.0 (Q4 2025), and $167000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 300,000.00
Mar 31, 2026 300,000.00
Dec 31, 2025 -136,000.00
Dec 31, 2025 -136,000.00
Sep 30, 2025 167,000.00
Sep 30, 2025 167,000.00
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 8,000.00
Mar 31, 2025 8,000.00
Dec 31, 2024 8,000.00
Dec 31, 2024 8,000.00
Sep 30, 2024 78,000.00
Sep 30, 2024 78,000.00
Jun 30, 2024 -35,296.00
Jun 30, 2024 -35,296.00
Mar 31, 2024 64,296.00
Mar 31, 2024 64,296.00
Dec 31, 2023 180,064.00
Dec 31, 2023 180,064.00
Sep 30, 2023 462,237.00
Sep 30, 2023 462,237.00
Jun 30, 2023 -97,840.00
Jun 30, 2023 -97,840.00
Mar 31, 2023 111,224.00
Mar 31, 2023 111,224.00
Dec 31, 2022 -18,723.00
Dec 31, 2022 -18,723.00
Sep 30, 2022 -421,057.00
Sep 30, 2022 -421,057.00
Jun 30, 2022 125,921.00
Jun 30, 2022 125,921.00
Mar 31, 2022 305,505.00
Mar 31, 2022 305,505.00
Dec 31, 2021 -6,649.00
Dec 31, 2021 -6,649.00
Sep 30, 2021 6,137.00
Sep 30, 2021 6,137.00
Dec 31, 2020 -24,674.00
Dec 31, 2020 -24,674.00
Sep 30, 2020 17,024.00
Sep 30, 2020 17,024.00
Jun 30, 2020 -102,522.00
Jun 30, 2020 -102,522.00
Mar 31, 2020 7,862.00
Mar 31, 2020 7,862.00
Dec 31, 2019 116,615.00
Dec 31, 2019 116,615.00
Sep 30, 2019 225.00
Sep 30, 2019 225.00
Jun 30, 2019 -58,604.00
Jun 30, 2019 -58,604.00
Mar 31, 2019 14,193.00
Mar 31, 2019 14,193.00
Dec 31, 2018 -1,960.00
Dec 31, 2018 -1,960.00
Sep 30, 2018 7,037.00
Sep 30, 2018 7,037.00
Jun 30, 2018 5,628.00
Jun 30, 2018 5,628.00
Mar 31, 2018 4,057.00
Mar 31, 2018 4,057.00
Dec 31, 2017 -2,993.00
Dec 31, 2017 -2,993.00
Sep 30, 2017 106.00
Sep 30, 2017 106.00
Jun 30, 2017 2,331.00
Jun 30, 2017 2,331.00
Mar 31, 2017 1,460.00
Mar 31, 2017 1,460.00
Dec 31, 2016 65,378.00
Dec 31, 2016 65,378.00